Ohcanbohtosat - Gil Redelman‐Sidi

  • Čájehuvvo 1 - 13 / 13
Aiddostahte ozu
  1. 1
    Could BCG be used to protect against COVID-19?

    Could BCG be used to protect against COVID-19? Dahkki Gil Redelman‐Sidi

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    BCG in Bladder Cancer Immunotherapy

    BCG in Bladder Cancer Immunotherapy Dahkki Song Jiang, Gil Redelman‐Sidi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Rapidly Growing Mycobacteria Infection in Patients with Cancer

    Rapidly Growing Mycobacteria Infection in Patients with Cancer Dahkki Gil Redelman‐Sidi, Kent A. Sepkowitz

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy

    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy Dahkki Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, Paul Elkington

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells

    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells Dahkki Gil Redelman‐Sidi, Gopa Iyer, David B. Solit, Michael S. Glickman

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways

    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways Dahkki Richa Gupta, Daniel Barkan, Gil Redelman‐Sidi, Stewart Shuman, Michael S. Glickman

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling

    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling Dahkki Anthony C. Antonelli, Anna Binyamin, Tobias M. Hohl, Michael S. Glickman, Gil Redelman‐Sidi

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune ch... Dahkki Gil Redelman‐Sidi, Olivier Michielin, Carlos Cervera, Camillo Ribi, José María Aguado, Mario Fernández‐Ruiz, Oriol Manuel

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer Dahkki Tilly Varughese, Ying Taur, Nina Cohen, M. Lia Palomba, Susan K. Seo, Tobias M. Hohl, Gil Redelman‐Sidi

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma Dahkki María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello, Chrisann Kyi, Michael A. Postow, Gil Redelman‐Sidi

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer

    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer Dahkki Gil Redelman‐Sidi, Anna Binyamin, Isabella Gaeta, Wilhelm Palm, Craig B. Thompson, Paul B. Romesser, Scott W. Lowe, Mukta Bagul, John G. Doench, David E. Root, Michael S. Glickman

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Determinants of Severity in Cancer Patients with COVID-19 Illness

    Determinants of Severity in Cancer Patients with COVID-19 Illness Dahkki Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, C. Ortiz, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Pré-impressão
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Determinants of COVID-19 disease severity in patients with cancer

    Determinants of COVID-19 disease severity in patients with cancer Dahkki Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, Cesar J. Figueroa, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: